Published in Neurosci Res on February 08, 2013
Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection. Pharmacol Ther (2015) 0.97
High bone mass in mice lacking Cx37 because of defective osteoclast differentiation. J Biol Chem (2014) 0.89
Regulation of gap junction channels by infectious agents and inflammation in the CNS. Front Cell Neurosci (2014) 0.83
Blockade of gap junction hemichannel protects secondary spinal cord injury from activated microglia-mediated glutamate exitoneurotoxicity. J Neurotrauma (2014) 0.79
Connexin: a potential novel target for protecting the central nervous system? Neural Regen Res (2015) 0.78
Changes in gap junction expression and function following ischemic injury of spinal cord white matter. J Neurophysiol (2014) 0.78
Connexins and their channels in inflammation. Crit Rev Biochem Mol Biol (2016) 0.77
Gap junction proteins and their role in spinal cord injury. Front Mol Neurosci (2015) 0.77
The action of mimetic peptides on connexins protects fibroblasts from the negative effects of ischemia reperfusion. Biol Open (2015) 0.76
Potentiation of Amitriptyline Anti-Hyperalgesic-Like Action By Astroglial Connexin 43 Inhibition in Neuropathic Rats. Sci Rep (2016) 0.75
Behavioral improvement and regulation of molecules related to neuroplasticity in ischemic rat spinal cord treated with PEDF. Neural Plast (2014) 0.75
Differences in the Cellular Response to Acute Spinal Cord Injury between Developing and Mature Rats Highlights the Potential Significance of the Inflammatory Response. Front Cell Neurosci (2017) 0.75
Characterisation of Peptide5 systemic administration for treating traumatic spinal cord injured rats. Exp Brain Res (2017) 0.75
Correlation between connexin and traumatic brain injury in patients. Brain Behav (2017) 0.75
Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications. Pharmacol Rev (2017) 0.75
Fibroblast network in rabbit sinoatrial node: structural and functional identification of homogeneous and heterogeneous cell coupling. Circ Res (2004) 2.90
Spatially and temporally distinct expression of fibroblast connexins after sheep ventricular infarction. Cardiovasc Res (2004) 1.57
Automated imaging of extended tissue volumes using confocal microscopy. Microsc Res Tech (2005) 1.49
Targeting connexin43 expression accelerates the rate of wound repair. Curr Biol (2003) 1.48
Structural and functional coupling of cardiac myocytes and fibroblasts. Adv Cardiol (2006) 1.18
Acute wound healing in the human central corneal epithelium appears to be independent of limbal stem cell influence. Invest Ophthalmol Vis Sci (2008) 1.17
Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury. Mol Cell Neurosci (2008) 1.16
Upregulation in astrocytic connexin 43 gap junction levels may exacerbate generalized seizures in mesial temporal lobe epilepsy. Brain Res (2002) 1.12
Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD. Respir Med (2010) 1.12
Connexin hemichannel blockade improves outcomes in a model of fetal ischemia. Ann Neurol (2012) 1.04
Role of connexin43 in central nervous system injury. Exp Neurol (2010) 1.03
Connexin 43 mimetic peptides reduce swelling, astrogliosis, and neuronal cell death after spinal cord injury. Cell Commun Adhes (2008) 1.00
Assessing RNA quality in postmortem human brain tissue. Exp Mol Pathol (2007) 0.99
Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia. Brain (2012) 0.98
Microglia density decreases with age in a mouse model of Huntington's disease. Glia (2003) 0.92
Acute action of rotenone on nigral dopaminergic neurons--involvement of reactive oxygen species and disruption of Ca2+ homeostasis. Eur J Neurosci (2009) 0.92
Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation. J Neurosci Res (2008) 0.90
Augmented locomotor recovery after spinal cord injury in the athymic nude rat. J Neurotrauma (2006) 0.90
Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus. Brain Res (2004) 0.89
Immunolocalization of gap junction protein connexin43 (GJA1) in the human retina and optic nerve. Invest Ophthalmol Vis Sci (2010) 0.89
Regulation of connexin43 gap junction protein triggers vascular recovery and healing in human ocular persistent epithelial defect wounds. J Membr Biol (2012) 0.89
Connexin expression patterns in the rat cornea: molecular evidence for communication compartments. Cornea (2003) 0.88
RAGE is expressed in pyramidal cells of the hippocampus following moderate hypoxic-ischemic brain injury in rats. Brain Res (2003) 0.87
Vascular degeneration in Parkinson's disease. Brain Pathol (2012) 0.87
Improved corneal wound healing through modulation of gap junction communication using connexin43-specific antisense oligodeoxynucleotides. Invest Ophthalmol Vis Sci (2012) 0.86
Dose-dependent protective effect of connexin43 mimetic peptide against neurodegeneration in an ex vivo model of epileptiform lesion. Epilepsy Res (2010) 0.86
Knockdown of connexin43-mediated regulation of the zone of polarizing activity in the developing chick limb leads to digit truncation. Dev Growth Differ (2002) 0.85
A key role for connexin hemichannels in spreading ischemic brain injury. Curr Drug Targets (2013) 0.84
Actions of fibroblast growth factor-8 in bone cells in vitro. Am J Physiol Endocrinol Metab (2009) 0.83
Delayed olfactory ensheathing cell transplants reduce nociception after dorsal root injury. Exp Neurol (2010) 0.83
Molecular profiling and cellular localization of connexin isoforms in the rat ciliary epithelium. Exp Eye Res (2002) 0.83
Distribution of EGF and its receptor in growing red deer antler. Cell Biol Int (2005) 0.82
High pressure-induced retinal ischaemia reperfusion causes upregulation of gap junction protein connexin43 prior to retinal ganglion cell loss. Exp Neurol (2011) 0.82
Antisense delivery and protein knockdown within the intact central nervous system. Front Biosci (2006) 0.82
Electrical perceptual threshold testing: a validation study. J Spinal Cord Med (2009) 0.82
Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release. Int J Pharm (2011) 0.82
Ion-activated in situ gelling systems for antisense oligodeoxynucleotide delivery to the ocular surface. Mol Pharm (2011) 0.81
Role of gap junctions in chronic pain. J Neurosci Res (2011) 0.81
The role of receptor for advanced glycation end products (RAGE) in neuronal differentiation. J Neurosci Res (2012) 0.81
Deleterious effects of high dose connexin 43 mimetic peptide infusion after cerebral ischaemia in near-term fetal sheep. Int J Mol Sci (2012) 0.81
The distribution of the growth factors FGF-2 and VEGF, and their receptors, in growing red deer antler. Tissue Cell (2007) 0.80
The use of connexin-based therapeutic approaches to target inflammatory diseases. Methods Mol Biol (2013) 0.80
Interrupting the inflammatory cycle in chronic diseases--do gap junctions provide the answer? Cell Biol Int (2008) 0.80
In vitro optimization of antisense oligodeoxynucleotide design: an example using the connexin gene family. J Biomol Tech (2006) 0.79
AGEs-RAGE mediated up-regulation of connexin43 in activated human microglial CHME-5 cells. Neurochem Int (2012) 0.79
Connexin and pannexin signaling pathways, an architectural blueprint for CNS physiology and pathology? Cell Mol Life Sci (2015) 0.78
Optimization of the Tet-On system for inducible expression of RAGE. J Biomol Tech (2006) 0.78
A model for ex vivo spinal cord segment culture--a tool for analysis of injury repair strategies. J Neurosci Methods (2010) 0.78
Comparison of bidirectional and bicistronic inducible systems for coexpression of connexin genes and fluorescent reporters. Anal Biochem (2012) 0.78
Connexin43 antisense oligodeoxynucleotide treatment down-regulates the inflammatory response in an in vitro interphase organotypic culture model of optic nerve ischaemia. J Clin Neurosci (2008) 0.78
Gap junction protein connexin43 (GJA1) in the human glaucomatous optic nerve head and retina. J Clin Neurosci (2010) 0.78
Severity of spinal cord injury in adult and infant rats after vertebral dislocation depends upon displacement but not speed. J Neurotrauma (2013) 0.77
Synergistic effect of chemical penetration enhancer and iontophoresis on transappendageal transport of oligodeoxynucleotides. Int J Pharm (2012) 0.77
Response of retinal Connexin43 to optic nerve injury. Invest Ophthalmol Vis Sci (2011) 0.77
Expression and distribution of creatine transporter and creatine kinase (brain isoform) in developing and mature rat cochlear tissues. Histochem Cell Biol (2012) 0.77
Focus on molecules: connexin 43--mind the gap. Exp Eye Res (2008) 0.77
In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides. Drug Deliv (2011) 0.76
Effect of low Mg2+ and bicuculline on cell survival in hippocampal slice cultures. Int J Neurosci (2010) 0.76
Connexin43 modulation inhibits scarring in a rabbit eye glaucoma trabeculectomy model. Inflammation (2012) 0.76
Cytotoxicity and vitreous stability of chemically modified connexin43 mimetic peptides for the treatment of optic neuropathy. J Pharm Sci (2013) 0.76
Intravitreal injection of lipoamino acid-modified connexin43 mimetic peptide enhances neuroprotection after retinal ischemia. Drug Deliv Transl Res (2015) 0.75
Keratocytes: more than a framework for the window. Clin Experiment Ophthalmol (2003) 0.75
Interleukin-17 deficiency improves locomotor recovery and tissue sparing after spinal cord contusion injury in mice. Neurosci Lett (2010) 0.75
In vivo and ex vivo in situ confocal analysis of a rat model demonstrating transient 'epithelialization of the endothelium'. Clin Experiment Ophthalmol (2002) 0.75
Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study. Int J Pharm (2011) 0.75
Transdifferentiation of chondrocytes into neuron-like cells induced by neuronal lineage specifying growth factors. Cell Biol Int (2014) 0.75
Whisker maps in marsupials: nerve lesions and critical periods. Anat Rec A Discov Mol Cell Evol Biol (2006) 0.75
A case study for outreach: the Auckland experience of the New Zealand Brain Bee Challenge. Neuroscientist (2010) 0.75
A Study Investigating a Possible Link Between Lens Protein in the Vitreous Fluid of Eyes After Uncomplicated Cataract Surgery and Chronic Cystoid Macular Edema. Asia Pac J Ophthalmol (Phila) (2015) 0.75